These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 28456611

  • 21. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 22. Transplantation for congenital heart disease is associated with an increased risk of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in children.
    Offor UT, Bacon CM, Roberts J, Powell J, Brodlie M, Wood K, Windebank KP, Flett J, Hewitt T, Rand V, Hasan A, Parry G, Gennery AR, Reinhardt Z, Bomken S.
    J Heart Lung Transplant; 2021 Jan; 40(1):24-32. PubMed ID: 33339556
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients.
    Chang YC, Young RR, Mavis AM, Chambers ET, Kirmani S, Kelly MS, Kalu IC, Smith MJ, Lugo DJ.
    PLoS One; 2022 Jan; 17(10):e0269766. PubMed ID: 36256635
    [Abstract] [Full Text] [Related]

  • 24. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 25. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 26. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 15; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 27. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Transplantation; 2012 Jan 15; 93(1):73-81. PubMed ID: 22129761
    [Abstract] [Full Text] [Related]

  • 28. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR.
    Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG.
    Pediatr Transplant; 2008 Jun 15; 12(4):464-8. PubMed ID: 18466434
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation.
    Wigle DA, Chaparro C, Humar A, Hutcheon MA, Chan CK, Keshavjee S.
    Transplantation; 2001 Dec 15; 72(11):1783-6. PubMed ID: 11740388
    [Abstract] [Full Text] [Related]

  • 30. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 31. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F, Loy M, Lunardi F, Marino D, Aversa SM, Rea F.
    Transpl Infect Dis; 2010 Aug 01; 12(4):342-6. PubMed ID: 20030794
    [Abstract] [Full Text] [Related]

  • 32. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qiu Y, Peng Y, Dharnidharka VR, Israni AK.
    Am J Kidney Dis; 2011 Dec 01; 58(6):971-80. PubMed ID: 21930332
    [Abstract] [Full Text] [Related]

  • 33. A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients.
    Chinnock R, Webber SA, Dipchand AI, Brown RN, George JF, Pediatric Heart Transplant Study.
    Am J Transplant; 2012 Nov 01; 12(11):3061-8. PubMed ID: 23072522
    [Abstract] [Full Text] [Related]

  • 34. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec 01; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 35. Epstein-Barr virus-associated smooth muscle tumors after lung transplantation.
    Hirama T, Tikkanen J, Pal P, Cleary S, Binnie M.
    Transpl Infect Dis; 2019 Jun 01; 21(3):e13068. PubMed ID: 30864272
    [Abstract] [Full Text] [Related]

  • 36. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb 01; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

  • 37. Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients.
    Mañez R, Breinig MK, Linden P, Kusne S, Torre-Cisneros J, Wilson J, Starzl TE, Ho M.
    Transpl Int; 1994 Feb 01; 7 Suppl 1():S235-7. PubMed ID: 11271213
    [Abstract] [Full Text] [Related]

  • 38. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
    Elidemir O, Kancherla BS, Schecter MG, McKenzie ED, Morales DL, Heinle JS, Mallory GB.
    Pediatr Transplant; 2009 Aug 01; 13(5):606-10. PubMed ID: 19017289
    [Abstract] [Full Text] [Related]

  • 39. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA.
    Clin Transplant; 2006 Aug 01; 20(3):389-93. PubMed ID: 16824159
    [Abstract] [Full Text] [Related]

  • 40. Post-transplant lymphoproliferative disorder after pancreas transplantation: a United Network for Organ Sharing database analysis.
    Jackson K, Ruppert K, Shapiro R.
    Clin Transplant; 2013 Aug 01; 27(6):888-94. PubMed ID: 24118329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.